Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

American Renal Associates Holdi (ARA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 204,207
  • Shares Outstanding, K 32,517
  • Annual Sales, $ 745,110 K
  • Annual Income, $ 4,860 K
  • 60-Month Beta 2.08
  • Price/Sales 0.24
  • Price/Cash Flow 3.28
  • Price/Book 2.21

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.01
  • Number of Estimates 1
  • High Estimate 0.01
  • Low Estimate 0.01
  • Prior Year 0.11
  • Growth Rate Est. (year over year) -90.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.07 +2.64%
on 05/24/19
8.01 -22.22%
on 05/06/19
-0.39 (-5.89%)
since 04/24/19
3-Month
5.48 +13.69%
on 04/17/19
14.10 -55.83%
on 03/01/19
-6.83 (-52.30%)
since 02/22/19
52-Week
5.48 +13.69%
on 04/17/19
23.99 -74.03%
on 08/23/18
-8.36 (-57.30%)
since 05/24/18

Most Recent Stories

More News
AMERICAN RENAL 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against American Renal Associates Holdings, Inc. - ARA

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with losses in excess of $100,000 that they have only until...

ARA : 6.23 (-0.80%)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against American Renal, Apple, Intersect, and Momo and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of American Renal Associates Holdings, Inc., Apple Inc., Intersect ENT, Inc., and...

ARA : 6.23 (-0.80%)
MOMO : 26.02 (-2.33%)
AAPL : 178.97 (-0.38%)
XENT : 25.19 (-0.55%)
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against American Renal Associates Holdings, Inc.

Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming May 28, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of American Renal Associates Holdings, Inc....

ARA : 6.23 (-0.80%)
MBT, HCSG & ARA - Bronstein, Gewirtz & Grossman, LLC Class Action Deadline

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints...

ARA : 6.23 (-0.80%)
MBT : 7.85 (-2.97%)
HCSG : 32.59 (+0.43%)
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS AAPL, ARA, INVVY, ORN INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits:

ARA : 6.23 (-0.80%)
AAPL : 178.97 (-0.38%)
ORN : 1.96 (+6.52%)
MBT, HCSG & ARA - Bronstein, Gewirtz & Grossman, LLC Class Action Update

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints...

ARA : 6.23 (-0.80%)
MBT : 7.85 (-2.97%)
HCSG : 32.59 (+0.43%)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Corcept, Mobile TeleSystems, Healthcare Services, and American Renal and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Corcept Therapeutics Incorporated, Mobile TeleSystems PJSC, Healthcare Services...

ARA : 6.23 (-0.80%)
CORT : 10.31 (-1.62%)
MBT : 7.85 (-2.97%)
HCSG : 32.59 (+0.43%)
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against American Renal Associates Holdings, Inc.

Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming May 28, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of American Renal Associates Holdings, Inc....

ARA : 6.23 (-0.80%)
ARA MAY 28 DEADLINE: Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against American Renal Associates Holdings, Inc. - ARA

Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of American Renal Associates Holdings, Inc. (NYSE: ARA) from August 10, 2016 through March...

ARA : 6.23 (-0.80%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in American Renal Associates Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline - ARA

Pomerantz LLP announces that a class action lawsuit has been filed against American Renal Associates Holdings, Inc. ("American Renal" or the "Company") (NYSE: ARA) and certain of its officers and directors....

ARA : 6.23 (-0.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade ARA with:

Business Summary

American Renal Associates Holdings, Inc. is a provider of dialysis services primarily in the United States. It also offers outpatient and inpatient dialysis treatments for patients suffering from chronic kidney failure. American Renal Associates Holdings, Inc. is based in Beverly, Massachusetts.

See More

Key Turning Points

2nd Resistance Point 6.47
1st Resistance Point 6.35
Last Price 6.23
1st Support Level 6.09
2nd Support Level 5.95

See More

52-Week High 23.99
Fibonacci 61.8% 16.92
Fibonacci 50% 14.73
Fibonacci 38.2% 12.55
Last Price 6.23
52-Week Low 5.48

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar